NEW YORK, Feb 7 – Software developer Genomica said Wednesday its fourth quarter 2000 revenues increased to $466,000, compared with $335,000 in the corresponding quarter in 1999, as the number of customers licensing the Discovery Manager software increased and additional users within existing customers rose.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.